Medo Specia Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.51 M
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 526.34%
- Profit Growth 3994.05%
- Ebitda 1200.45%
- Net Worth 254.19%
- Total Assets 264.85%
About Medo Specia Laboratories
Medo Specia Laboratories Private Limited (MSLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 1999 and has a history of 25 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Doc-N- Cliq Labs Private Limited. The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.51 M.
The company currently has active open charges totaling ₹1.00 M.
Krishna Balasubramanian and Ashwin Prasad serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200MH1999PTC121496
-
Company No.
121496
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Aug 1999
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medo Specia Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Balasubramanian
|
Director | 03-Aug-2009 | Current |
|
Ashwin Prasad
|
Director | 27-Jul-2016 | Current |
Financial Performance of Medo Specia Laboratories.
Medo Specia Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 526.34% increase. The company also saw a substantial improvement in profitability, with a 3994.05% increase in profit. The company's net worth Soared by an impressive increase of 254.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medo Specia Laboratories?
In 2021, Medo Specia Laboratories had a promoter holding of 80.89% and a public holding of 19.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tidal Healthcare Private LimitedKrishna Balasubramanian and Ashwin Prasad are mutual person
-
Tidal Laboratories Private LimitedKrishna Balasubramanian is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2000 | Central Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Medo Specia Laboratories?
Unlock and access historical data on people associated with Medo Specia Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medo Specia Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medo Specia Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
